Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Radiol. Aug 28, 2013; 5(8): 295-303
Published online Aug 28, 2013. doi: 10.4329/wjr.v5.i8.295
Table 1 Patient characteristics
Clinical characteristicsPatients (n = 24)
Age (yr)65 ± 11 (40-86)
Male gender88%
Body mass index28.4 ± 5.3 (19.2-40.7)
Hypertension58%
Hyperlipidemia75%
Diabetes mellitus37.5%
Prior tobacco use29%
Positive family history62.5%
Prior MI > 5 yr ago75%
Prior PCI21%
Prior CABG21%
Infarct region
Anterior9
Lateral4
Inferior5
Septal7
Apical8
Examination characteristics
Beta-blocker administration2
Nitroglycerin administration15
Mean heart rate63 ± 12 bpm
Mean contrast amount150 mL
DECT dose-length product (mGycm)808 ± 191
DECT effective dose (mSv)11.3 ± 2.7
Left ventricle
End diastolic volume173 ± 60 mL
Ejection fraction55% ± 17%
Table 2 Diagnostic accuracy, specificity and sensitivity
AccuracySpecificitySensitivityPPVNPV
Definite
(Grade 3)
Hyperenhancement
100 kVp90.4%99.4%35.2%90.5%90.4%
95%CI (84.3-94.2)95%CI (97.7-99.8)95%CI (19.4-55.0)95%CI (66.5-97.8)95%CI (83.6-94.5)
140 kVp84.5%97.1%9.1%33.3%86.6%
95%CI (76.1-90.4)95%CI (92.5-98.8)95%CI (2.7-26.6)95%CI (9.4-70.6)95%CI (77.5-92.4)
Mixed88.0%97.6%29.1%66.7%89.4%
95%CI (81.1-92.6)95%CI (94.0-99.1)95%CI (14.0-50.9)95%CI (35.6-87.8)95%CI (81.5-94.2)
Iodine Only85.2%97.5%11.1%42.9%86.8%
95%CI (78.3-90.2)95%CI (94.2-99.0)95%CI (4.0-27.0)95%CI (14.8-76.4)95%CI (79.3-91.9)
Definite or Possible
95%CI (Combined Grades 2 and 3)
Hyperenhancement
100 kVp86.7%90.0%66.7%52.2%94.3%
95%CI (82.4-90.1)95%CI (85.8-93.1)95%CI (53.6-77.6)95%CI (34.7-69.2)95%CI (89.1-97.1)
140 kVp75.0%79.3%49.1%28.1%90.4%
95%CI (68.0-80.9)95%CI (71.4-85.4)95%CI (34.1-64.3)95%CI (15.6-45.2)95%CI (82.7-94.9)
Mixed76.5%82.7%38.2%26.6%89.1%
95%CI (69.6-82.2)95%CI (76.1-87.8)95%CI (22.7-56.5)95%CI (13.9-44.9)95%CI (80.9-94.1)
Iodine Only83.6%90.1%44.4%42.9%90.7%
95%CI (77.3-88.4)95%CI (83.6-94.2)95%CI (27.7-62.5)95%CI (24.6-63.3)95%CI (84.0-94.8)